Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We?
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Arrhythmogenic cardiomyopathy (ACM) is a cardiomyopathy characterized by the occurrence of a high risk of life-threatening ventricular arrhythmias and sudden cardiac death even at presentation. Diagnosis, evolution and outcomes in adults have been extensively reported, but little data in pediatric population are available. Risk stratification in this particular setting is still a matter of debate and new risk factors are needed in a model of an ever more “individualized medicine”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Arrhythmogenic cardiomyopathy (ACM) is a genetically and phenotypically heterogeneous myocardial disorder characterized by progressive cardiomyocyte loss, immune cell infiltration, and fibro-fatty replacement of the ventricular myocardium [1,2,3,4,5].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.840827 · Cited by 2,676
McKenna, W. J., Thiene, G., Nava, A., Fontaliran, F., Blomstrom-Lundqvist, C., Fontaine, G., & Camerini, F. (1994) · Heart · doi:10.1136/hrt.71.3.215 · Cited by 1,653
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq025 · Cited by 1,612 · cited 3×
“Notably, the identification of a pathogenic/likely pathogenic genetic variant was listed as a “major” criterion [8].”
BackgroundMethodInfluentialTowbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H., Darrieux, F. C. C., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.05.007 · Cited by 846
Arrhythmogenic Right Ventricular Cardiomyopathy
Corrado, D., Link, M. S., & Calkins, H. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1509267 · Cited by 736
Left-Dominant Arrhythmogenic Cardiomyopathy
Sen-Chowdhry, S., Syrris, P., Prasad, S. K., Hughes, S. E., Merrifield, R., Ward, D., Pennell, D. J., & McKenna, W. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.019 · Cited by 661
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria
Corrado, D., Perazzolo Marra, M., Zorzi, A., Beffagna, G., Cipriani, A., Lazzari, M. D., Migliore, F., Pilichou, K., Rampazzo, A., Rigato, I., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.06.005 · Cited by 582 · cited 1×
“, idiopathic ventricular tachycardias) [9,10].”
Corrado, D., Wichter, T., Link, M. S., Hauer, R. N. W., Marchlinski, F. E., Anastasakis, A., Bauce, B., Basso, C., Brunckhorst, C., Tsatsopoulou, A., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.017944 · Cited by 513 · cited 1×
“While the minor risk factors are more heterogeneous and include proband status, male gender, electrical instability (spontaneous VAs or induced at electrophysiological study), younger age, complex genotype and the extent of structural heart disease [1,18].”
BackgroundSmith, E. D., Lakdawala, N. K., Papoutsidakis, N., Aubert, G., Mazzanti, A., McCanta, A. C., Agarwal, P. P., Arscott, P., Dellefave-Castillo, L. M., Vorovich, E. E., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044934 · Cited by 504 · cited 1×
“Even a “DSP cardiomyopathy” has been identified as a kind of distinct form of ACM characterized by myocardial inflammation, fibrosis and LV systolic dysfunction in the later stages, predisposing to ventricular arrhythmias [27].”
BackgroundBhonsale, A., Groeneweg, J. A., James, C. A., Dooijes, D., Tichnell, C., Jongbloed, J. D. H., Murray, B., te Riele, A. S. J. M., van den Berg, M. P., Bikker, H., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu509 · Cited by 426
Corrado, D., van Tintelen, P. J., McKenna, W. J., Hauer, R. N. W., Anastastakis, A., Asimaki, A., Basso, C., Bauce, B., Brunckhorst, C., Bucciarelli-Ducci, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz669 · Cited by 366
Cadrin-Tourigny, J., Bosman, L. P., Nozza, A., Wang, W., Tadros, R., Bhonsale, A., Bourfiss, M., Fortier, A., Lie, Ø. H., Saguner, A. M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz103 · Cited by 264
James, C. A., Jongbloed, J. D. H., Hershberger, R. E., Morales, A., Judge, D. P., Syrris, P., Pilichou, K., Domingo, A. M., Murray, B., Cadrin-Tourigny, J., et al. (2021) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.120.003273 · Cited by 238 · cited 1×
“Recently, Aquaro also proposed the presentation of the CMR phenotype for risk stratification [16].”
BackgroundRisk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
Calkins, H., Corrado, D., & Marcus, F. (2017) · Circulation · doi:10.1161/circulationaha.117.030792 · Cited by 206
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy
Chelko, S. P., Asimaki, A., Lowenthal, J., Bueno-Beti, C., Bedja, D., Scalco, A., Amat-Alarcon, N., Andersen, P., Judge, D. P., Tung, L., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040676 · Cited by 192 · cited 1×
“The discovery of serum anti-DSG2, anti-heart and anti-intercalated disk auto-antibodies supported also an autoimmunity hypothesis, but larger cohorts and prospective studies are needed to confirm this [31,38,39].”
ResultEvolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
Corrado, D., Zorzi, A., Cipriani, A., Bauce, B., Bariani, R., Beffagna, G., De Lazzari, M., Migliore, F., Pilichou, K., Rampazzo, A., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021987 · Cited by 166 · cited 1×
“, idiopathic ventricular tachycardias) [9,10].”
Aquaro, G. D., Luca, A. D., Cappelletto, C., Raimondi, F., Bianco, F., Botto, N., Lesizza, P., Grigoratos, C., Minati, M., Dell'Omodarme, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.023 · Cited by 163 · cited 1×
“This may result in a redefinition of the 5-year risk score: in case of RV phenotype, the 5-year risk score should be used and ICD considered for a risk >15%, while in case of LV involvement, the average risk was >15% by default and ICD should be recommended [22].”
MethodArrhythmogenic right ventricular cardiomyopathy: Clinical presentation, diagnosis, and management
Sen-Chowdhry, S., Lowe, M. D., Sporton, S. C., & McKenna, W. J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.028 · Cited by 161 · cited 1×
“reported four different and progressive stages of the disease evolution [11].”
BackgroundChatterjee, D., Fatah, M., Akdis, D., Spears, D. A., Koopmann, T. T., Mittal, K., Rafiq, M. A., Cattanach, B. M., Zhao, Q., Healey, J. S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy567 · Cited by 161 · cited 1×
“The discovery of serum anti-DSG2, anti-heart and anti-intercalated disk auto-antibodies supported also an autoimmunity hypothesis, but larger cohorts and prospective studies are needed to confirm this [31,38,39].”
ResultVerstraelen, T. E., van Lint, F. H. M., Bosman, L. P., de Brouwer, R., Proost, V. M., Abeln, B. G. S., Taha, K., Zwinderman, A. H., Dickhoff, C., Oomen, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab294 · Cited by 161 · cited 2×
“for the carriers of the PLNpArg14 [13,15,25,26].”
‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy
Bariani, R., Cipriani, A., Rizzo, S., Celeghin, R., Bueno Marinas, M., Giorgi, B., De Gaspari, M., Rigato, I., Leoni, L., Zorzi, A., et al. (2021) · EP Europace · doi:10.1093/europace/euaa343 · Cited by 154 · cited 3×
“There is a “hot phase” of clinical presentation in children with more frequent chest pain episodes, higher values of troponin I/CPK and more edema/hyperemia at cardiac magnetic resonance (CMR) than in ACM adult patients [12,36].”
BackgroundResultDaliento, L., Turrini, P., Nava, A. K., Rizzoli, G., Angelini, A., Buja, G., Scognamiglio, R., & Thiene, G. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00433-q · Cited by 151 · cited 1×
“This author reported that in young patients with ACM there is a greater amount of fibrosis detected on endomyocardial biopsy (EBM) and a higher incidence of ventricular fibrillation (VF) and SCD than in adults [28].”
BackgroundArrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population
Riele, A. S. J. M. T., James, C. A., Sawant, A. C., Bhonsale, A., Groeneweg, J. A., Mast, T. P., Murray, B. A., Tichnell, C., Dooijes, D., van Tintelen, J. P., et al. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.08.004 · Cited by 122
Cadrin-Tourigny, J., Bosman, L. P., Wang, W., Tadros, R., Bhonsale, A., Bourfiss, M., Lie, Ø. H., Saguner, A. M., Svensson, A., Andorin, A., et al. (2021) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008509 · Cited by 118 · cited 2×
“This apparently weird conclusion may be explained by the concept that an early electrical phase and electrical instability may lead to unstable VAs independently by the structural substrate [21].”
BackgroundArrhythmogenic left ventricular cardiomyopathy
Corrado, D., & Basso, C. (2021) · Heart · doi:10.1136/heartjnl-2020-316944 · Cited by 113 · cited 2×
“In these c ses, p thogenic or lik ly pathogenic va iants of ACM- elated genes allow the differentiation f om LV-domin nt ACM t the other phenocopies [5].”
BackgroundPhenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents
DeWitt, E. S., Chandler, S. F., Hylind, R. J., Beausejour Ladouceur, V., Blume, E. D., VanderPluym, C., Powell, A. J., Fynn-Thompson, F., Roberts, A. E., Sanders, S. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.022 · Cited by 94 · cited 2×
“There is a “hot phase” of clinical presentation in children with more frequent chest pain episodes, higher values of troponin I/CPK and more edema/hyperemia at cardiac magnetic resonance (CMR) than in ACM adult patients [12,36].”
BackgroundResultEtoom, Y., Govindapillai, S., Hamilton, R. M., Manlhiot, C., Yoo, S., Farhan, M., Sarikouch, S., Peters, B., McCrindle, B. W., & Grosse‐Wortmann, L. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.041 · Cited by 91
Bauce, B., Rampazzo, A., Basso, C., Mazzotti, E., Rigato, I., Steriotis, A., Beffagna, G., Lorenzon, A., De Bortoli, M., Pilichou, K., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.06.026 · Cited by 90 · cited 1×
“She confirmed the high risk of life-threatening VAs in the young and reported an important correlation between DSP mutation and a worse disease progression in terms of RV and LV dilatation/dysfunction, moving toward the concept that ACM is not only a RV disease [29].”
BackgroundGilotra, N. A., Bhonsale, A., James, C. A., te Riele, A. S. J., Murray, B., Tichnell, C., Sawant, A., Ong, C. S., Judge, D. P., Russell, S. D., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003819 · Cited by 74 · cited 1×
“Given the high life-threatening arrhythmic risk, this condition remains an electrophysiologist managed disease, however, with the higher efficacy in SCD prevention, a longer life expectancy of these patients is wished with subsequent higher incidence of HF and needing of HT in the future [24].”
BackgroundMartins, D., Ovaert, C., Khraiche, D., Boddaert, N., Bonnet, D., & Raimondi, F. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.116 · Cited by 63 · cited 2×
“Another important feature of ACM in pediatric patients is the recurrent myocarditislike episodes [37].”
BackgroundResultState of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy
Patel, V. M., Asatryan, B., Siripanthong, B., Munroe, P. B., OWENS, A. T., Lopes, L. R., Khanji, M. Y., Protonotarios, A., Santangeli, P., Muser, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186615 · Cited by 45
Mattesi, G., Cipriani, A., Bauce, B., Rigato, I., Zorzi, A., & Corrado, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102212 · Cited by 43
Deshpande, S. R., Herman, H. K., Quigley, P. C., Shinnick, J. K., Cundiff, C. A., Caltharp, S. A., & Shehata, B. M. (2016) · Pediatric Cardiology · doi:10.1007/s00246-015-1327-x · Cited by 42 · cited 1×
“, ECG criteria) were less applicable in children [32].”
BackgroundFogel, M. A., Weinberg, P. M., Harris, M. A., & Rhodes, L. A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.045 · Cited by 37
Yoo, S., Grosse‐Wortmann, L., & Hamilton, R. M. (2010) · Korean Circulation Journal · doi:10.4070/kcj.2010.40.8.357 · Cited by 33
Sequeira, I. B., Kirsh, J. A., Hamilton, R. M., Russell, J. L., & Gross, G. J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.03.056 · Cited by 32 · cited 1×
“, highlighting the impossibility to derive “definite conclusions” after this test in case of suspicion of ACM in pediatric setting [42].”
BackgroundChungsomprasong, P., Hamilton, R., Luining, W., Fatah, M., Yoo, S.-J., & Grosse-Wortmann, L. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.11.020 · Cited by 31 · cited 1×
“These important findings were confirmed by Chungsomprasong, who reported the involvement of the LV in children and adolescents as a stronger predictor of adverse outcome including the need for heart transplantation [30].”
BackgroundArrhythmogenic Cardiomyopathy—Current Treatment and Future Options
Migliore, F., Mattesi, G., Zorzi, A., Bauce, B., Rigato, I., Corrado, D., & Cipriani, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132750 · Cited by 29 · cited 3×
“Heart failure (HF) is another complication occurring in the advanced stages of the disease and it requires treatment with traditional pharmacological therapies or advanced mechanical support and heart transplant (HT) [15].”
BackgroundRiele, A. S. J. M. T., James, C. A., Calkins, H. G., & Tsatsopoulou, A. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.750916 · Cited by 29
Roudijk, R. W., Verheul, L., Bosman, L. P., Bourfiss, M., Breur, J. M. P. J., Slieker, M. G., Blank, A. C., Dooijes, D., van der Heijden, J. F., van den Heuvel, F., et al. (2022) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2021.09.001 · Cited by 23 · cited 1×
“In this regard, electrical characteristics in terms of ECG, PVC burden, complex PVC and CMR results are of fundamental importance for diagnosis and also for identifying disease progression [41].”
BackgroundCicenia, M., Cantarutti, N., Adorisio, R., Silvetti, M. S., Secinaro, A., Ciancarella, P., Mambro, C. D., Magliozzi, M., Novelli, A., Amodeo, A., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.01.008 · Cited by 19 · cited 1×
“Furthermore, the electrophysiologic study (EPS) showed inducible VT in only a minority of patients, differently from the other studies, and electroanatomic mapping (EAM) showed high prevalence of low voltage areas with fragmented electrocardiograms [43,44].”
ResultSelf-citationCorrado, D., Migliore, F., & Zorzi, A. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab355 · Cited by 16 · cited 2×
“for the carriers of the PLNpArg14 [13,15,25,26].”
Clinical Presentation and Heart Failure in Children With Arrhythmogenic Cardiomyopathy
Surget, E., Maltret, A., Raimondi, F., Fressart, V., Bonnet, D., Gandjbakhch, E., & Khraiche, D. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010346 · Cited by 15 · cited 1×
“Conversely, pediatric patients of post-pubertal age (group 2) had more ventricular tachycardias than the initial presentation, and the RV dominant form was the predominant phenotype together with the higher presence of PKP2 variants [40].”
BackgroundArrhythmogenic right ventricular cardiomyopathy in the pediatric population
Cohen, M. I., & Atkins, M. B. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000937 · Cited by 9 · cited 1×
“It is essential to remember that the arrhythmic risk is always present over the time, for the progressivity of the disease itself, and can change rapidly and becoming higher, so the risk assessment must be done periodically, especially at young age [23].”
BackgroundZorzi, A., Graziano, F., & Corrado, D. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.02.029 · Cited by 7 · cited 1×
“Furthermore, the electrophysiologic study (EPS) showed inducible VT in only a minority of patients, differently from the other studies, and electroanatomic mapping (EAM) showed high prevalence of low voltage areas with fragmented electrocardiograms [43,44].”
Result
Cited by
Inherited Arrhythmias in the Pediatric Population: An Updated Overview
Mariani, M. V., Pierucci, N., Fanisio, F., Laviola, D., Silvetti, G., Piro, A., Fazia, V. M. L., Chimenti, C., Rebecchi, M., Drago, F., et al. (2024) · Medicina · doi:10.3390/medicina60010094 · Cited by 46
“ARVC is an inherited disorder characterized by progressive heart muscle disease, a high risk of SCD, and ventricular tachyarrhythmias [33].”
BackgroundSelf-citationArrhythmogenic Right Ventricular Cardiomyopathy in Children: A Systematic Review
Moisă, Ș. M., Spoială, E.-L., Cinteză, E. E., Vatasescu, R. G., Butnariu, L. I., Brinza, C., & Burlacu, A. (2024) · Diagnostics · doi:10.3390/diagnostics14020175 · Cited by 12
“The importance of an early diagnosis is supported by a higher risk of sudden cardiac death in the pediatric population, probably due to more frequent myocarditis-like episodes with consequent electrical instability [7].”
The Role of Multimodality Imaging in Pediatric Cardiomyopathies
Moscatelli, S., Leo, I., Bianco, F., Borrelli, N., Beltrami, M., Garofalo, M., Milano, E., Bisaccia, G., Iellamo, F., Bassareo, P., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144866 · Cited by 12
2025 Clinical practice guidelines for Ventricular arrhythmias of the heart and Sudden cardiac death
Mikhailov, E. N., Gizatulina, T. P., Lebedev, D. S., Golukhova, E. Z., Kharlap, M. S., Лебедева, В. К., Bagnenko, S. F., Artyukhina, Е. А., Babokin, V. E., Batalov, R. E., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6670 · Cited by 17
Cardiovascular Involvement in Pediatric FLNC Variants: A Case Series of Fourteen Patients
Baban, A., Alesi, V., Magliozzi, M., Parlapiano, G., Genovese, S., Cicenia, M., Loddo, S., Lodato, V., Chiara, L. D., Fattori, F., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9100332 · Cited by 9
Self-citation
Metadata
- Authors
- Cicenia, M., & Drago, F.
- Affiliations
- Bambino Gesù Children's Hospital (IT)
- Corresponding author
- Drago, Fabrizio
- Venue
- Journal of Cardiovascular Development and Disease
- Publisher
- MDPI AG
- Published
- 2022-03-27
- Volume
- 9
- Issue
- 4
- Pages
- 98
- ISSN
- 2308-3425 (ISSN-L)
- PMC
- PMC9024428
- OpenAlex
- W4220862708
- Cited by
- 21
- References
- 45
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 2
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Cardiovascular Development and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- arrhythmogenic cardiomyopathy, sudden cardiac death, ventricular arrhythmias, risk stratification, disease progression, diagnosis, personalized medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
